183 related articles for article (PubMed ID: 17950969)
21. Rat strain differences in peripheral and central serotonin transporter protein expression and function.
Fernandez F; Sarre S; Launay JM; Aguerre S; Guyonnet-Dupérat V; Moisan MP; Ebinger G; Michotte Y; Mormède P; Chaouloff F
Eur J Neurosci; 2003 Feb; 17(3):494-506. PubMed ID: 12581167
[TBL] [Abstract][Full Text] [Related]
22. Significant correlation between 14C-5-HT uptake by and 3H-paroxetine binding to platelets from healthy volunteers.
Maguire K; Tuckwell V; Pereira A; Dean B; Singh B
Biol Psychiatry; 1993 Sep; 34(6):356-60. PubMed ID: 8218602
[TBL] [Abstract][Full Text] [Related]
23. Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation.
Berger JS; Becker RC; Kuhn C; Helms MJ; Ortel TL; Williams R
Thromb Haemost; 2013 Jan; 109(1):85-92. PubMed ID: 23223800
[TBL] [Abstract][Full Text] [Related]
24. Determinants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorder.
Ishiguro S; Watanabe T; Ueda M; Saeki Y; Hayashi Y; Akiyama K; Saito A; Kato K; Inoue Y; Shimoda K
Eur J Clin Pharmacol; 2011 Dec; 67(12):1213-21. PubMed ID: 21688171
[TBL] [Abstract][Full Text] [Related]
25. The lack of genotype-phenotype relationship between platelet serotonin concentration and serotonin transporter gene promoter polymorphism in healthy subjects.
Pivac N; Nedic G; Mustapic M; Babic A; Stipcevic T; Borovecki F; Hajnsek S; Muck-Seler D
Neurosci Lett; 2009 Oct; 462(1):45-8. PubMed ID: 19573575
[TBL] [Abstract][Full Text] [Related]
26. A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.
Kenna GA; Zywiak WH; McGeary JE; Leggio L; McGeary C; Wang S; Grenga A; Swift RM
Alcohol Clin Exp Res; 2009 Feb; 33(2):315-23. PubMed ID: 19032576
[TBL] [Abstract][Full Text] [Related]
27. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features.
Fichtner CG; O'Connor FL; Yeoh HC; Arora RC; Crayton JW
Life Sci; 1995; 57(2):PL37-44. PubMed ID: 7603291
[TBL] [Abstract][Full Text] [Related]
28. Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism.
Stoltenberg SF; Twitchell GR; Hanna GL; Cook EH; Fitzgerald HE; Zucker RA; Little KY
Am J Med Genet; 2002 Mar; 114(2):230-4. PubMed ID: 11857587
[TBL] [Abstract][Full Text] [Related]
29. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos.
Figueras G; Pérez V; San Martino O; Alvarez E; Artigas F
Biol Psychiatry; 1999 Aug; 46(4):518-24. PubMed ID: 10459402
[TBL] [Abstract][Full Text] [Related]
30. Serotonin transporter promoter polymorphism genotype is associated with behavioral disinhibition and negative affect in children of alcoholics.
Twitchell GR; Hanna GL; Cook EH; Stoltenberg SF; Fitzgerald And HE; Zucker RA
Alcohol Clin Exp Res; 2001 Jul; 25(7):953-9. PubMed ID: 11505018
[TBL] [Abstract][Full Text] [Related]
31. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
[TBL] [Abstract][Full Text] [Related]
32. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
Spigset O; Allard P; Mjörndal T
Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
[TBL] [Abstract][Full Text] [Related]
33. Seasonal variations in the binding of [3H]paroxetine to the platelet serotonin transporter sites in African-American cocaine-dependent patients and healthy volunteers.
Patkar AA; Berrettini WH; Lundy A; Murray HW; Hill KP; Vergare MJ; Weinstein SP
Hum Psychopharmacol; 2003 Mar; 18(2):103-11. PubMed ID: 12590403
[TBL] [Abstract][Full Text] [Related]
34. Platelet serotonergic predictors of clinical improvement in obsessive compulsive disorder.
Delorme R; Chabane N; Callebert J; Falissard B; Mouren-Siméoni MC; Rouillon F; Launay JM; Leboyer M
J Clin Psychopharmacol; 2004 Feb; 24(1):18-23. PubMed ID: 14709942
[TBL] [Abstract][Full Text] [Related]
35. Serotonin transporter promoter polymorphism and dopaminergic sensitivity in alcoholics.
Budde H; Sander T; Wernicke C; Müller A; Gallinat J; Schmidt LG; Smolka MN
J Neural Transm (Vienna); 2010 Jan; 117(1):133-8. PubMed ID: 19885717
[TBL] [Abstract][Full Text] [Related]
36. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder.
Cook EH; Arora RC; Anderson GM; Berry-Kravis EM; Yan SY; Yeoh HC; Sklena PJ; Charak DA; Leventhal BL
Life Sci; 1993; 52(25):2005-15. PubMed ID: 7684805
[TBL] [Abstract][Full Text] [Related]
37. Serotonin transporter gene promoter polymorphisms modify the association between paroxetine serotonin transporter occupancy and clinical response in major depressive disorder.
Ruhé HG; Ooteman W; Booij J; Michel MC; Moeton M; Baas F; Schene AH
Pharmacogenet Genomics; 2009 Jan; 19(1):67-76. PubMed ID: 18987562
[TBL] [Abstract][Full Text] [Related]
38. Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents.
Nobile M; Begni B; Giorda R; Frigerio A; Marino C; Molteni M; Ferrarese C; Battaglia M
J Am Acad Child Adolesc Psychiatry; 1999 Nov; 38(11):1396-402. PubMed ID: 10560226
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism in the serotonin transporter gene and response to treatment in African American cocaine and alcohol-abusing individuals.
Mannelli P; Patkar AA; Murray HW; Certa K; Peindl K; Mattila-Evenden M; Berrettini WH
Addict Biol; 2005 Sep; 10(3):261-8. PubMed ID: 16109588
[TBL] [Abstract][Full Text] [Related]
40. Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers.
Patkar AA; Gopalakrishnan R; Berrettini WH; Weinstein SP; Vergare MJ; Leone FT
Psychopharmacology (Berl); 2003 Mar; 166(3):221-7. PubMed ID: 12589524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
